Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Rioth

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Surgical Oncology|October 12, 2019
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision makingChloe Friedman, Madison Lyon, Robert J Torphy, et al.
Pharmacogenomics|February 21, 2020
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experienceChristina L Aquilante, David P Kao, Katy E Trinkley, et al.
Molecular Cancer Therapeutics|October 22, 2017
ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> IsoformsKasey L Couts, Judson Bemis, Jacqueline A Turner, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
International Journal of Cancer|July 13, 2024
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profilingJacqueline A Turner, Robert J Van Gulick, William A Robinson, et al.
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Surgical Oncology|October 12, 2019
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision makingChloe Friedman, Madison Lyon, Robert J Torphy, et al.
Pharmacogenomics|February 21, 2020
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experienceChristina L Aquilante, David P Kao, Katy E Trinkley, et al.
Molecular Cancer Therapeutics|October 22, 2017
ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> IsoformsKasey L Couts, Judson Bemis, Jacqueline A Turner, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
International Journal of Cancer|July 13, 2024
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profilingJacqueline A Turner, Robert J Van Gulick, William A Robinson, et al.
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
Pageof 2